ExodusPoint Capital Management, LP
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1736225
NEW YORK, NY
Position in KALV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,568,525
+$3,244,540 QoQ
Shares Held
177,274
+783.7% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#52
of 182 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $375,055,315 across 144 Biotechnology names. KALV ranks #28 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
178,779 | $33,798,169 | |
| 2 | INSM |
INSMED Inc
|
148,133 | $24,222,708 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
227,084 | $17,051,737 | |
| 4 | ABVX |
Abivax S.A.
|
140,262 | $15,618,173 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
372,175 | $14,325,015 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
317,351 | $12,767,030 | |
| 7 | BHVN |
Biohaven Ltd.
|
1,501,099 | $12,699,297 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
173,425 | $10,084,663 |
All Filings in KALV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,568,525 | 177,274 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $323,985 | 20,061 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | $171,578 | 14,467 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $331,204 | 34,393 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $280,620 | 31,180 | Shares | Sole | 2023-08-11 | |
| 2021-09-30 | $334,568 | 19,173 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||